AMPK promotes tolerance to Ras pathway inhibition by activating autophagy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-04-04

AUTHORS

S Sanduja, Y Feng, R A Mathis, E S Sokol, F Reinhardt, R Halaban, P B Gupta

ABSTRACT

Targeted inhibitors of oncogenic Ras (rat sarcoma viral oncogene)-Raf signaling have shown great promise in the clinic, but resistance remains a major challenge: 30% of tumors with pathway mutations do not respond to targeted inhibitors, and of the 70% that do respond, all eventually develop resistance. Before cancer cells acquire resistance, they respond to initial drug treatment either by undergoing apoptosis ('addiction') or by surviving treatment albeit with reduced growth ('tolerance'). As these drug-tolerant cells serve as a reservoir from which resistant cells eventually emerge, inhibiting the pathways that confer tolerance could potentially delay or even prevent recurrence. Here, we show that melanomas and other cancers acquire tolerance to Ras-Raf pathway inhibitors by activating autophagy, which is mediated by the cellular energy sensor AMP-activated protein kinase (AMPK). Blocking this AMPK-mediated autophagy sensitizes drug-tolerant melanomas to Ras-Raf pathway inhibitors. Conversely, activating AMPK signaling and autophagy enables melanomas that would otherwise be addicted to the Ras-Raf pathway to instead tolerate pathway inhibition. These findings identify a key mechanism of tolerance to Ras-Raf pathway inhibitors and suggest that blocking either AMPK or autophagy in combination with these targeted inhibitors could increase tumor regression and decrease the likelihood of eventual recurrence. More... »

PAGES

5295-5303

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/onc.2016.70

DOI

http://dx.doi.org/10.1038/onc.2016.70

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038532670

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27041569


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "AMP-Activated Protein Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autophagy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Tolerance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "MCF-7 Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins B-raf", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ras Proteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Whitehead Institute for Biomedical Research, Cambridge, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.270301.7", 
          "name": [
            "Whitehead Institute for Biomedical Research, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sanduja", 
        "givenName": "S", 
        "id": "sg:person.0666666556.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666666556.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Whitehead Institute for Biomedical Research, Cambridge, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.270301.7", 
          "name": [
            "Whitehead Institute for Biomedical Research, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feng", 
        "givenName": "Y", 
        "id": "sg:person.01006557057.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006557057.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.116068.8", 
          "name": [
            "Whitehead Institute for Biomedical Research, Cambridge, MA, USA", 
            "Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mathis", 
        "givenName": "R A", 
        "id": "sg:person.0752067605.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752067605.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.116068.8", 
          "name": [
            "Whitehead Institute for Biomedical Research, Cambridge, MA, USA", 
            "Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sokol", 
        "givenName": "E S", 
        "id": "sg:person.0766624146.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766624146.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Whitehead Institute for Biomedical Research, Cambridge, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.270301.7", 
          "name": [
            "Whitehead Institute for Biomedical Research, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reinhardt", 
        "givenName": "F", 
        "id": "sg:person.01112613466.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112613466.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Halaban", 
        "givenName": "R", 
        "id": "sg:person.053601122.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053601122.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Harvard Stem Cell Institute, Cambridge, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.511171.2", 
          "name": [
            "Whitehead Institute for Biomedical Research, Cambridge, MA, USA", 
            "Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA", 
            "Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA", 
            "Harvard Stem Cell Institute, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gupta", 
        "givenName": "P B", 
        "id": "sg:person.01107374617.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107374617.09"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ncb2152", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049008067", 
          "https://doi.org/10.1038/ncb2152"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35056522", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052681968", 
          "https://doi.org/10.1038/35056522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/gb-2006-7-10-r100", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040889351", 
          "https://doi.org/10.1186/gb-2006-7-10-r100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm1660", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001954283", 
          "https://doi.org/10.1038/nrm1660"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature09626", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035733152", 
          "https://doi.org/10.1038/nature09626"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature10662", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028208693", 
          "https://doi.org/10.1038/nature10662"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35074129", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005772949", 
          "https://doi.org/10.1038/35074129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ng1634", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004568587", 
          "https://doi.org/10.1038/ng1634"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature09454", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032620847", 
          "https://doi.org/10.1038/nature09454"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm2249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021292551", 
          "https://doi.org/10.1038/nrm2249"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1479-5876-8-39", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050587923", 
          "https://doi.org/10.1186/1479-5876-8-39"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature09627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005907434", 
          "https://doi.org/10.1038/nature09627"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-04-04", 
    "datePublishedReg": "2016-04-04", 
    "description": "Targeted inhibitors of oncogenic Ras (rat sarcoma viral oncogene)-Raf signaling have shown great promise in the clinic, but resistance remains a major challenge: 30% of tumors with pathway mutations do not respond to targeted inhibitors, and of the 70% that do respond, all eventually develop resistance. Before cancer cells acquire resistance, they respond to initial drug treatment either by undergoing apoptosis ('addiction') or by surviving treatment albeit with reduced growth ('tolerance'). As these drug-tolerant cells serve as a reservoir from which resistant cells eventually emerge, inhibiting the pathways that confer tolerance could potentially delay or even prevent recurrence. Here, we show that melanomas and other cancers acquire tolerance to Ras-Raf pathway inhibitors by activating autophagy, which is mediated by the cellular energy sensor AMP-activated protein kinase (AMPK). Blocking this AMPK-mediated autophagy sensitizes drug-tolerant melanomas to Ras-Raf pathway inhibitors. Conversely, activating AMPK signaling and autophagy enables melanomas that would otherwise be addicted to the Ras-Raf pathway to instead tolerate pathway inhibition. These findings identify a key mechanism of tolerance to Ras-Raf pathway inhibitors and suggest that blocking either AMPK or autophagy in combination with these targeted inhibitors could increase tumor regression and decrease the likelihood of eventual recurrence.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/onc.2016.70", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2440220", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3000960", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2440219", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6663720", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "40", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "35"
      }
    ], 
    "keywords": [
      "cellular energy sensor AMP", 
      "pathway inhibitor", 
      "energy sensor AMP", 
      "targeted inhibitors", 
      "Ras-Raf pathway", 
      "drug-tolerant cells", 
      "pathway inhibition", 
      "oncogenic Ras", 
      "protein kinase", 
      "Raf signaling", 
      "Ras pathway inhibition", 
      "reduced growth", 
      "AMPK", 
      "autophagy", 
      "pathway mutations", 
      "cancer cells", 
      "resistant cells", 
      "key mechanism", 
      "pathway", 
      "inhibitors", 
      "cells", 
      "tolerance", 
      "kinase", 
      "signaling", 
      "inhibition", 
      "mutations", 
      "apoptosis", 
      "resistance", 
      "great promise", 
      "RA", 
      "growth", 
      "major challenge", 
      "melanoma", 
      "AMP", 
      "mechanism", 
      "drug treatment", 
      "cancer", 
      "tumor regression", 
      "reservoir", 
      "treatment", 
      "combination", 
      "findings", 
      "promise", 
      "tumors", 
      "initial drug treatment", 
      "likelihood", 
      "challenges", 
      "eventual recurrence", 
      "rats", 
      "regression", 
      "recurrence", 
      "clinic"
    ], 
    "name": "AMPK promotes tolerance to Ras pathway inhibition by activating autophagy", 
    "pagination": "5295-5303", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038532670"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/onc.2016.70"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27041569"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/onc.2016.70", 
      "https://app.dimensions.ai/details/publication/pub.1038532670"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_717.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/onc.2016.70"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/onc.2016.70'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/onc.2016.70'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/onc.2016.70'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/onc.2016.70'


 

This table displays all metadata directly associated to this object as RDF triples.

280 TRIPLES      21 PREDICATES      103 URIs      82 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/onc.2016.70 schema:about N0631d16bffd847859a37a154dd14ded1
2 N0ce3a848213547c4bfa691d6797fde6a
3 N2fb8ba2648d74f5ca49341927e6ed650
4 N726847402c4a4d57aa3e97de622335ee
5 N7a7987deb213463eb23013f70e0afb5c
6 N830ba59379e840ce9eebbecd8935c3c7
7 N96ab8a54edfe423f85c8214814918410
8 Na7bfd2552ee1476ab88b94d04a689f7d
9 Nc7aebcad395442188b1dec754323bfbb
10 Nccb4b712fd3c4ca4983e1b83a648a87f
11 Ndd2937dd82944171a42f42cf27c48a7b
12 Nf97c404bf95147a9a5b303d961c29668
13 Nfd1c2f38993b4cc7953337105c5a1adf
14 anzsrc-for:11
15 anzsrc-for:1103
16 anzsrc-for:1112
17 schema:author N041d6bcb95b24ba29d5ff33049af7e7c
18 schema:citation sg:pub.10.1038/35056522
19 sg:pub.10.1038/35074129
20 sg:pub.10.1038/nature09454
21 sg:pub.10.1038/nature09626
22 sg:pub.10.1038/nature09627
23 sg:pub.10.1038/nature10662
24 sg:pub.10.1038/ncb2152
25 sg:pub.10.1038/ng1634
26 sg:pub.10.1038/nrm1660
27 sg:pub.10.1038/nrm2249
28 sg:pub.10.1186/1479-5876-8-39
29 sg:pub.10.1186/gb-2006-7-10-r100
30 schema:datePublished 2016-04-04
31 schema:datePublishedReg 2016-04-04
32 schema:description Targeted inhibitors of oncogenic Ras (rat sarcoma viral oncogene)-Raf signaling have shown great promise in the clinic, but resistance remains a major challenge: 30% of tumors with pathway mutations do not respond to targeted inhibitors, and of the 70% that do respond, all eventually develop resistance. Before cancer cells acquire resistance, they respond to initial drug treatment either by undergoing apoptosis ('addiction') or by surviving treatment albeit with reduced growth ('tolerance'). As these drug-tolerant cells serve as a reservoir from which resistant cells eventually emerge, inhibiting the pathways that confer tolerance could potentially delay or even prevent recurrence. Here, we show that melanomas and other cancers acquire tolerance to Ras-Raf pathway inhibitors by activating autophagy, which is mediated by the cellular energy sensor AMP-activated protein kinase (AMPK). Blocking this AMPK-mediated autophagy sensitizes drug-tolerant melanomas to Ras-Raf pathway inhibitors. Conversely, activating AMPK signaling and autophagy enables melanomas that would otherwise be addicted to the Ras-Raf pathway to instead tolerate pathway inhibition. These findings identify a key mechanism of tolerance to Ras-Raf pathway inhibitors and suggest that blocking either AMPK or autophagy in combination with these targeted inhibitors could increase tumor regression and decrease the likelihood of eventual recurrence.
33 schema:genre article
34 schema:isAccessibleForFree true
35 schema:isPartOf Nba72b7d106624973b3d0a9c44c451121
36 Nd3e66896c6bb4d6187cff433b62007b6
37 sg:journal.1097543
38 schema:keywords AMP
39 AMPK
40 RA
41 Raf signaling
42 Ras pathway inhibition
43 Ras-Raf pathway
44 apoptosis
45 autophagy
46 cancer
47 cancer cells
48 cells
49 cellular energy sensor AMP
50 challenges
51 clinic
52 combination
53 drug treatment
54 drug-tolerant cells
55 energy sensor AMP
56 eventual recurrence
57 findings
58 great promise
59 growth
60 inhibition
61 inhibitors
62 initial drug treatment
63 key mechanism
64 kinase
65 likelihood
66 major challenge
67 mechanism
68 melanoma
69 mutations
70 oncogenic Ras
71 pathway
72 pathway inhibition
73 pathway inhibitor
74 pathway mutations
75 promise
76 protein kinase
77 rats
78 recurrence
79 reduced growth
80 regression
81 reservoir
82 resistance
83 resistant cells
84 signaling
85 targeted inhibitors
86 tolerance
87 treatment
88 tumor regression
89 tumors
90 schema:name AMPK promotes tolerance to Ras pathway inhibition by activating autophagy
91 schema:pagination 5295-5303
92 schema:productId N2580d4f3abcb4516bfdfffcdd992f0ce
93 N34c59c3f3fb64987987b7f98bb93f7d4
94 N389ce7125bb54a79b3022ffdb2e314e0
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038532670
96 https://doi.org/10.1038/onc.2016.70
97 schema:sdDatePublished 2022-10-01T06:42
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N300097aa505449a8a57b00d29566f82a
100 schema:url https://doi.org/10.1038/onc.2016.70
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N041d6bcb95b24ba29d5ff33049af7e7c rdf:first sg:person.0666666556.32
105 rdf:rest N99eebb966eb043a0910fcf59d8dc8ad6
106 N0631d16bffd847859a37a154dd14ded1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name MCF-7 Cells
108 rdf:type schema:DefinedTerm
109 N0ce3a848213547c4bfa691d6797fde6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Autophagy
111 rdf:type schema:DefinedTerm
112 N2580d4f3abcb4516bfdfffcdd992f0ce schema:name dimensions_id
113 schema:value pub.1038532670
114 rdf:type schema:PropertyValue
115 N2fb8ba2648d74f5ca49341927e6ed650 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Apoptosis
117 rdf:type schema:DefinedTerm
118 N300097aa505449a8a57b00d29566f82a schema:name Springer Nature - SN SciGraph project
119 rdf:type schema:Organization
120 N34c59c3f3fb64987987b7f98bb93f7d4 schema:name doi
121 schema:value 10.1038/onc.2016.70
122 rdf:type schema:PropertyValue
123 N389ce7125bb54a79b3022ffdb2e314e0 schema:name pubmed_id
124 schema:value 27041569
125 rdf:type schema:PropertyValue
126 N4e3bc060656943698db012cb0c136b2b rdf:first sg:person.01107374617.09
127 rdf:rest rdf:nil
128 N6ca1b08b08b5427e8488865f50c21380 rdf:first sg:person.0766624146.49
129 rdf:rest Nf5ee0875ba2e4886b9e57b5df9f0e0b1
130 N726847402c4a4d57aa3e97de622335ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Protein Kinase Inhibitors
132 rdf:type schema:DefinedTerm
133 N7a7987deb213463eb23013f70e0afb5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Melanoma
135 rdf:type schema:DefinedTerm
136 N830ba59379e840ce9eebbecd8935c3c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Humans
138 rdf:type schema:DefinedTerm
139 N96ab8a54edfe423f85c8214814918410 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name ras Proteins
141 rdf:type schema:DefinedTerm
142 N99eebb966eb043a0910fcf59d8dc8ad6 rdf:first sg:person.01006557057.54
143 rdf:rest Ne5f1919d9fb24564ab5dd03666c00770
144 Na7bfd2552ee1476ab88b94d04a689f7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Drug Resistance, Neoplasm
146 rdf:type schema:DefinedTerm
147 Nba72b7d106624973b3d0a9c44c451121 schema:issueNumber 40
148 rdf:type schema:PublicationIssue
149 Nc7aebcad395442188b1dec754323bfbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Cell Line, Tumor
151 rdf:type schema:DefinedTerm
152 Nccb4b712fd3c4ca4983e1b83a648a87f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Proto-Oncogene Proteins B-raf
154 rdf:type schema:DefinedTerm
155 Nd3e66896c6bb4d6187cff433b62007b6 schema:volumeNumber 35
156 rdf:type schema:PublicationVolume
157 Ndd2937dd82944171a42f42cf27c48a7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Signal Transduction
159 rdf:type schema:DefinedTerm
160 Ne5f1919d9fb24564ab5dd03666c00770 rdf:first sg:person.0752067605.70
161 rdf:rest N6ca1b08b08b5427e8488865f50c21380
162 Nf5ee0875ba2e4886b9e57b5df9f0e0b1 rdf:first sg:person.01112613466.54
163 rdf:rest Nfb17ed4e4c204342ae977d4de7e1a5e4
164 Nf97c404bf95147a9a5b303d961c29668 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Drug Tolerance
166 rdf:type schema:DefinedTerm
167 Nfb17ed4e4c204342ae977d4de7e1a5e4 rdf:first sg:person.053601122.01
168 rdf:rest N4e3bc060656943698db012cb0c136b2b
169 Nfd1c2f38993b4cc7953337105c5a1adf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name AMP-Activated Protein Kinases
171 rdf:type schema:DefinedTerm
172 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
173 schema:name Medical and Health Sciences
174 rdf:type schema:DefinedTerm
175 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
176 schema:name Clinical Sciences
177 rdf:type schema:DefinedTerm
178 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
179 schema:name Oncology and Carcinogenesis
180 rdf:type schema:DefinedTerm
181 sg:grant.2440219 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2016.70
182 rdf:type schema:MonetaryGrant
183 sg:grant.2440220 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2016.70
184 rdf:type schema:MonetaryGrant
185 sg:grant.3000960 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2016.70
186 rdf:type schema:MonetaryGrant
187 sg:grant.6663720 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2016.70
188 rdf:type schema:MonetaryGrant
189 sg:journal.1097543 schema:issn 0950-9232
190 1476-5594
191 schema:name Oncogene
192 schema:publisher Springer Nature
193 rdf:type schema:Periodical
194 sg:person.01006557057.54 schema:affiliation grid-institutes:grid.270301.7
195 schema:familyName Feng
196 schema:givenName Y
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006557057.54
198 rdf:type schema:Person
199 sg:person.01107374617.09 schema:affiliation grid-institutes:grid.511171.2
200 schema:familyName Gupta
201 schema:givenName P B
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107374617.09
203 rdf:type schema:Person
204 sg:person.01112613466.54 schema:affiliation grid-institutes:grid.270301.7
205 schema:familyName Reinhardt
206 schema:givenName F
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112613466.54
208 rdf:type schema:Person
209 sg:person.053601122.01 schema:affiliation grid-institutes:grid.47100.32
210 schema:familyName Halaban
211 schema:givenName R
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053601122.01
213 rdf:type schema:Person
214 sg:person.0666666556.32 schema:affiliation grid-institutes:grid.270301.7
215 schema:familyName Sanduja
216 schema:givenName S
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666666556.32
218 rdf:type schema:Person
219 sg:person.0752067605.70 schema:affiliation grid-institutes:grid.116068.8
220 schema:familyName Mathis
221 schema:givenName R A
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752067605.70
223 rdf:type schema:Person
224 sg:person.0766624146.49 schema:affiliation grid-institutes:grid.116068.8
225 schema:familyName Sokol
226 schema:givenName E S
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766624146.49
228 rdf:type schema:Person
229 sg:pub.10.1038/35056522 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052681968
230 https://doi.org/10.1038/35056522
231 rdf:type schema:CreativeWork
232 sg:pub.10.1038/35074129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005772949
233 https://doi.org/10.1038/35074129
234 rdf:type schema:CreativeWork
235 sg:pub.10.1038/nature09454 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032620847
236 https://doi.org/10.1038/nature09454
237 rdf:type schema:CreativeWork
238 sg:pub.10.1038/nature09626 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035733152
239 https://doi.org/10.1038/nature09626
240 rdf:type schema:CreativeWork
241 sg:pub.10.1038/nature09627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005907434
242 https://doi.org/10.1038/nature09627
243 rdf:type schema:CreativeWork
244 sg:pub.10.1038/nature10662 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028208693
245 https://doi.org/10.1038/nature10662
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/ncb2152 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049008067
248 https://doi.org/10.1038/ncb2152
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/ng1634 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004568587
251 https://doi.org/10.1038/ng1634
252 rdf:type schema:CreativeWork
253 sg:pub.10.1038/nrm1660 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001954283
254 https://doi.org/10.1038/nrm1660
255 rdf:type schema:CreativeWork
256 sg:pub.10.1038/nrm2249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021292551
257 https://doi.org/10.1038/nrm2249
258 rdf:type schema:CreativeWork
259 sg:pub.10.1186/1479-5876-8-39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050587923
260 https://doi.org/10.1186/1479-5876-8-39
261 rdf:type schema:CreativeWork
262 sg:pub.10.1186/gb-2006-7-10-r100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040889351
263 https://doi.org/10.1186/gb-2006-7-10-r100
264 rdf:type schema:CreativeWork
265 grid-institutes:grid.116068.8 schema:alternateName Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
266 schema:name Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
267 Whitehead Institute for Biomedical Research, Cambridge, MA, USA
268 rdf:type schema:Organization
269 grid-institutes:grid.270301.7 schema:alternateName Whitehead Institute for Biomedical Research, Cambridge, MA, USA
270 schema:name Whitehead Institute for Biomedical Research, Cambridge, MA, USA
271 rdf:type schema:Organization
272 grid-institutes:grid.47100.32 schema:alternateName Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA
273 schema:name Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA
274 rdf:type schema:Organization
275 grid-institutes:grid.511171.2 schema:alternateName Harvard Stem Cell Institute, Cambridge, MA, USA
276 schema:name Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
277 Harvard Stem Cell Institute, Cambridge, MA, USA
278 Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA
279 Whitehead Institute for Biomedical Research, Cambridge, MA, USA
280 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...